Sitagliptin
Overview
Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used as an oral antihyperglycemic agent for the treatment of type 2 diabetes. It works by increasing incretin levels, which inhibit glucagon release, thereby increasing insulin secretion.
API suppliers (51)
Suppliers of Sitagliptin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 44 of 51 suppliers.
22 of 51 hold a GMP certificate on record in the EU or UK registers
- Biocon LimitedIndia5 active DMF
- DR REDDYS LABORATORIES LTD4 active DMF GMP on record
- TAPI NL BVNetherlands3 active DMF
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia3 active DMF GMP on record
- HIKAL LTDPakistan3 active DMF
- RUYUAN HEC PHARM CO LTD3 active DMF
- ALIVUS LIFE SCIENCES LTDIndia3 active DMF GMP on record
- Zhejiang Jingsheng Pharmaceutical Co., Ltd.China2 active DMF
- AMI LIFESCIENCES PRIVATE LTDIndia2 active DMF GMP on record
- HONOUR LAB LTDIndia2 active DMF GMP on record
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)India2 active DMF
- LEE PHARMA LTDIndia2 active DMF GMP on record
- Sun Pharmaceutical Industries LimitedIndia2 active DMF GMP on record
- APITORIA PHARMA PRIVATE LTDIndia2 active DMF GMP on record
- FUXIN LONG RUI PHARMACEUTICAL CO LTD2 active DMF
- Zydus Lifesciences LimitedIndia2 active DMF GMP on record
- MOREPEN LABORATORIES LTDIndia2 active DMF GMP on record
- MSN PHARMACHEM PRIVATE LTDIndia2 active DMF
- Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- Shandong New Time Pharmaceutical Co Ltd1 active DMF GMP on record
- ALMELO PRIVATE LTDIndia1 active DMF
- WAVELENGTH ENTERPRISES LTDIsrael1 active DMF GMP on record
- Apotex Inc.Canada1 active DMF
- HARMAN FINOCHEM LTDIndia1 active DMF GMP on record
- Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.China1 active DMF
Showing 25 of 51 suppliers — see the full list in the app.
Patent & exclusivity (US)
Per the FDA Orange Book (16 approved US products), the latest listed US patent on Sitagliptin expires 23 Oct 2040 and exclusivity 24 Nov 2026. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Sitagliptin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.